Your browser doesn't support javascript.
loading
Impact of gender on safety and efficacy of Rivaroxaban in adolescents & young adults with venous thromboembolism.
Krause, Manuela; Henningsen, Anna; Torge, Antje; Juhl, David; Junker, Ralf; Kenet, Gili; Kowalski, Dorothee; Limperger, Verena; Mesters, Rolf; Rocke, Angela; Shneyder, Maria; Clausnizer, Hartmut; Schiesewitz, Hanna; Nowak-Göttl, Ulrike.
Afiliação
  • Krause M; Deutsche Klinik für Diagnostik, Wiesbaden, Germany.
  • Henningsen A; Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Kiel, Germany.
  • Torge A; Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Kiel, Germany.
  • Juhl D; Center of Blood Transfusion, University Hospital Schleswig-Holstein, Campus Lübeck, Germany.
  • Junker R; Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Kiel, Germany; Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Lübeck, Germany.
  • Kenet G; Thrombosis Unit, National Hemophilia Center, Tel Hashomer and the Sackler Medical School, Tel Aviv University, Israel.
  • Kowalski D; Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Kiel, Germany.
  • Limperger V; Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Kiel, Germany; Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Lübeck, Germany.
  • Mesters R; Department of Medicine/Hematology & Oncology, Univ. Hospital of Münster, Germany.
  • Anonymous; Department of Anesthesiology and Intensive Care Medicine, Charité - Universitäts-medizin Berlin, Campus Charité Mitte and Campus Virchow-Klinikum, Berlin, Germany.
  • Rocke A; Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Kiel, Germany; Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Lübeck, Germany.
  • Shneyder M; Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Lübeck, Germany.
  • Clausnizer H; Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Kiel, Germany.
  • Schiesewitz H; Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Kiel, Germany.
  • Nowak-Göttl U; Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Kiel, Germany; Institute of Clinical Chemistry, Univ. Hospital Schleswig-Holstein, Campus Lübeck, Germany. Electronic address: leagottl@uksh.de.
Thromb Res ; 148: 145-151, 2016 Dec.
Article em En | MEDLINE | ID: mdl-27687905
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tromboembolia Venosa / Inibidores do Fator Xa / Rivaroxabana Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tromboembolia Venosa / Inibidores do Fator Xa / Rivaroxabana Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article